ArticleClinical & translational immunology2022

Genome-wide off-target analyses of CRISPR/Cas9-mediated T-cell receptor engineering in primary human T cells.

Theresa Kaeuferle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.